SSU72: A Potential Drug Target Or Biomarker (G29101)

Target Name: SSU72

NCBI ID: G29101

SSU72

SSU72: A Potential Drug Target Or Biomarker

SSU72, short for Secure Similarity Underlaying 72, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been implicated in the development and progression of many diseases, including cancer. In recent years, researchers have been interested in studying SSU72 as a potential drug target or biomarker.

The protein encoded by the SSU72 gene is a member of the Sec7 family of proteins, which are known for their ability to mediate protein-protein interactions and to regulate cell division. SSU72 is unique among its family members in that it is expressed in the nuclei of various cell types and is involved in the regulation of mitosis, meiosis, and apoptosis.

One of the key functions of SSU72 is its role in the regulation of the cytoskeleton. During mitosis, SSU72 helps to maintain the integrity of the cytoskeleton and ensures that chromosomes are properly aligned and divided. It also plays a role in the regulation of the spindle The formation and function of the body.

In addition to its role in cell division, SSU72 has also been shown to be involved in the regulation of cell growth and the control of cell survival. It has been shown to play a role in the regulation of angiogenesis, the formation of new blood vessels , and in the regulation of tissue repair.

The potential drug target status of SSU72 is due to its unique structure and the fact that it is expressed in various tissues. It is thought to be a good candidate for a drug target due to its ability to interact with a variety of different proteins and its involved in the regulation of cellular processes that are important for human health and disease.

Another potential mechanism by which SSU72 may be targeted by drugs is its role in the regulation of the immune response. It has been shown to play a role in the regulation of T cell development and function, and has been implicated in the development of cancer in the immune system.

In conclusion, SSU72 is a protein that has been shown to play a role in the regulation of cell division, cytoskeleton, cell growth, and immune response. Its unique structure and its expression in various tissues make it an interesting candidate for a drug target or biomarker. Further research is needed to fully understand its functions and its potential as a drug.

Protein Name: SSU72 Homolog, RNA Polymerase II CTD Phosphatase

Functions: Protein phosphatase that catalyzes the dephosphorylation of the C-terminal domain of RNA polymerase II. Plays a role in RNA processing and termination. Plays a role in pre-mRNA polyadenylation via its interaction with SYMPK

The "SSU72 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SSU72 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets